spacer
home > epc > Winter 2016
PUBLICATIONS

European Pharmaceutical Contractor

epc
Winter 2016

   
Text
PDF
bullet
Business and Finance
Drug Prices

Adding Value


Putting a price tag on drugs is a challenge but by implementing two increasingly common pricing strategies, it is possible to satisfy both seller and buyer, claim ERTs Stephen Raymond and Matthew Reaney.
 
view
download pdf
bullet
Marketplace & Business
Mergers and Acquisitions

Shared Vision


Dealing with employees is, arguably, the most important aspect of M&A. Mike Straw at Achieve Breakthrough reveals what company executives can do to ensure a smooth transition.
 
view
download pdf
M&A Activity Report

Across the Border


There is a noticeable shift towards acquiring in growing markets overseas, and investment in personalised medicine EPC summaries these twin trends within M&A activity.
 
view
download pdf
bullet
Legal & Regulatory
Clinical Evaluation

Conform to the Norm: Part 1


In this first of a two-part article, Terry Winchell at GCP Innovative Dynamics offers an in-depth analysis of the FDA clinical investigator disqualification process, including early beginnings and how the FDA interprets its role.
 
view
download pdf
bullet
Electronic Solutions
Pharmacovigilance and Social Media

Keep Talking


Digital media is set to alter the way patients and companies communicate, observes Supriya Desai at Sciformix Corporation, but this change is not without risk.
 
view
download pdf
bullet
Review
Event Review

Latest on Life Sciences


EPC reports on the CMS Global Lifesciences Forum 2015, in which the biggest issues driving the sector were discussed.
 
view
download pdf
bullet
Manufacturing Environment
Medical Device Regulations

Step by Step

Chris Rule
at Maetrics advises medical device manufacturers to take great care in producing clinical evaluation reports, and proposes a 10-step plan to successfully comply with new regulations in 2018.
 
view
download pdf
   
spacer



Published quarterly in
February, May,
August and November

News and Press Releases

RoslinCT to Participate in the Northern Alliance Advanced Therapies Treatment Centre

RoslinCT, a UK-based cell and gene therapy contract manufacturing organisation, is delighted to be part of the Northern Alliance Advanced Therapies Treatment Centre (NAATTC) consortium. As an industry partner within the consortium, RoslinCT will provide advice on the development, manufacture and clinical supply of cell, gene and tissue engineered therapies.
More info >>

White Papers

Is Your Biobank Ready for the Challenge of Biomarker-based Research?

BioFortis

Targeted and personalized studies with well-defined patient segmentation biomarkers are becoming the norm in clinical trials. This increased interest in molecular biomarker studies necessitates a rigor and sophistication in sample management within the clinical trial context that is often not supported either by traditional clinical trial management software (CTMS), or biobanking systems.  Download our Next Generation Biobanking whitepaper and learn about how to overcome the key challenges in clinical trial sample management from working in a distributed network of partners and stakeholder to managing consents and generating scientific insights.
More info >>

Industry Events

On Helix 2018

10-11 July 2018, The Cambridge Building, Babraham Research Campus

ON Helix is a two-day event aimed at informing delegates of how to turn early stage inventions and ideas into innovative health treatments (new medicines, novel biomarkers, useful medical devices or improved medical practices).
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement